Home Syracuse University College of Law NYSTAR - New York State Foundation for Science, Technology & Innovation
Search
   Go

Buffalo BioBlower Technologies, LLC




1. What is Buffalo BioBlower?

Buffalo BioBlower Technologies, LLC develops high-volume air sterilizers for joint development partners in commercial and military markets. As a gas compresses, the temperature and pressure of the gas increases. The BioBlower uses this natural phenomenon to instantaneously heat large-volume airstreams to 240°C, killing all airborne pathogens immediately. By placing a catalyst in the heated airstream, the BioBlower also removes VOCs and chemical contaminants from the air. To conserve energy, the heated air flows through a heat exchanger to cool the air down to near room temperature by transferring the heat to the incoming airstream.

The scalable nature of the BioBlower satisfies an array of applications. Any environment that requires sterile, chemical-free air can utilize a BioBlower. Examples of market environments include hospitals and health care facilities, military, emergency response, pharmaceutical production, food processing, private or public transportation, vehicles, laboratories, public and commercial buildings, and private homes.

Currently, other technologies exist for air purification, but all have disadvantages. For example, HEPA filters require periodic filter changes, concentrate pathogens rather than destroy them, clog easily, and may need to be treated as hazardous waste. Rather than merely trapping pathogens, the BioBlower kills all of them instantly. Other air sterilization methods use harsh toxic chemicals, potentially rendering the sterilized air unbreathable. In addition, UV radiation filters do not effectively sterilize the air. Finally, resistive heating sterilizers require higher temperatures and energy input, and may not kill all pathogens due to an inability to heat the air uniformly. The BioBlower effectively kills all pathogens without the use of harsh chemicals and does not require significantly higher temperature or energy input.

2. How was Buffalo BioBlower created and funded? What relationships were involved in bringing this technology to market?

In 2005, John A. Lordi, Ph.D. and Professor James F. Grarvey founded Buffalo BioBlower Technologies to develop and commercialize the compressive heating technology developed at the research laboratories of the University at Buffalo. Buffalo BioBlower exclusively licensed the BioBlower patent from the University at Buffalo.

Buffalo BioBlower Technologies has received significant support to aid in the development of its technology, including an investment from the Western New York Business Development Fund to support an initial proof-of-concept demonstration and matching grants from the UB Center for Advanced Biomedical and Bioengineering Technology. In 2006, Buffalo BioBlower received a $1.5 million Department of Defense contract that enabled the development of a prototype that reduced the size of the unit by a factor of four and reduced power consumption by a factor of ten. In addition, a $690,000 NYSTAR grant was received to aid in the adaption of the technology for commercial health care use. Currently, Buffalo BioBlower is completing a $740,000 DoD contract to develop a commercial prototype and to scale the BioBlower for applications that range in size from small vehicles to entire buildings.

3. Does Buffalo BioBlower hold any patents or other intellectual property?

Buffalo BioBlower has broad patent coverage in the United States (#7,335,333 and #7,799,272) and in Israel (#170,095), and patent applications are under review in Canada and the European Union.

4. Would you briefly describe Buffalo BioBlower’s business plan?

Buffalo BioBlower’s primary strategy is to partner with market leaders that have a good understanding of their markets’ needs and have the resources required to quickly penetrate their markets. The initial product development targets are in military, industrial and healthcare market niches. Additional equity investment is needed to support these joint development projects.

5. What is the current status of the company? In what publicly disclosed research and development efforts has Buffalo BioBlower recently been engaged?

Buffalo BioBlower is demonstrating prototypes for manufacturing and pharmaceutical markets and continues to develop its technology for specific military needs.

6. Who is on the Buffalo BioBlower team?

John A. Lordi, Ph.D., Chief Executive Officer & Co-inventor
Professor James F. Garvey, Ph.D., Chief Scientific Officer & Co-inventor
Robert J Martin, Chief Operating Officer
James Senneff, Senior Engineer
Ronald Drzewiecki, Consulting Engineer
James B. Wulf, P.E., Consulting Engineer